UV-Visible Spectrophotometric Method Development and Validation for The Estimation of Levodopa in Nasal Medium
Abstract
Objective: The objective of this study was to develop a straightforward UV-Visible spectrophotometric method for the quantitative analysis of Levodopa in both its pure form and pharmaceutical dosage forms, followed by validation of the proposed analytical method in accordance with standard guidelines.
Material and Methods: Quantitative analysis of Levodopa was performed using a UV-Visible double-beam spectrophotometer, with measurements taken at the maximum absorbance wavelength (280 nm) in phosphate-buffered saline (pH 6.4) to simulate the nasal environment. The drug was initially characterized through melting point determination using the capillary fusion method and further confirmed by Fourier Transform Infrared (FTIR) spectroscopy. A novel UV-Visible spectrophotometric method was developed for the estimation of Levodopa, and its validation was conducted in accordance with International Conference on Harmonisation (ICH) guidelines, evaluating key analytical parameters such as linearity, accuracy, precision, repeatability, sensitivity, robustness and ruggedness.
Result: The melting point of the drug was determined to be 277 °C, which aligns with its reported reference range, confirming its identity. Further structural confirmation was achieved through spectral interpretation. A linear relationship was observed for Levodopa in the concentration range of 1–6 µg/mL, exhibiting a regression coefficient (R²) of 0.9988, indicating strong linearity. The precision of the method was assessed, with intraday and interday relative standard deviation (RSD) values found to be 0.734% and 0.720%, respectively—both within acceptable limits. To evaluate the sensitivity of the developed method, the limit of detection (LOD) and limit of quantification (LOQ) were calculated as 0.810 µg/mL and 2.452 µg/mL, respectively.
Conclusion: The UV spectrophotometric method developed and validated for the analysis of Levodopa demonstrated acceptable linearity, accuracy, and precision, and proved to be cost-effective, making it suitable for routine quality control and quantitative evaluation of its pharmaceutical formulations.
Keywords: UV visible spectrometric, Levodopa, validation, nasal media, saline phosphate buffer pH 6.4
Keywords:
UV visible spectrometric, Levodopa, Validation, Nasal media, Saline Phosphate buffer pH 6.4DOI
https://doi.org/10.22270/jddt.v15i10.7344References
1. Fahn S. The history of dopamine and levodopa in the treatment of Parkinson's disease: Dopamine and Levodopa in the Treatment of PD. Mov Disord 2008;23(S3):S497-S508; https://doi.org/10.1002/mds.22028 PMid:18781671
2. Ebada MA, Alkanj S, Ebada M, et al. Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson's Disease: A Systematic Review. CNSNDDT 2019;18(4):317-325; https://doi.org/10.2174/1871527318666190314101314 PMid:30868968
3. Jacovella G, Milazzotto F. [Study on the interactions between ditazol and anticoagulants in patients with intracardiac valvular prostheses]. Clin Ter 1977;80(5):425-431. https://doi.org/10.1016/1385-7258(77)90056-7
4. Anonymous. United States Pharmacopoeia, National Formulary. 2007. n.d.
5. Anonymous. Indian Pharmacopoeia. 2007; III. n.d.
6. Shin JY, Park H, Ahn YH, et al. Neuroprotective effect of L ‐dopa on dopaminergic neurons is comparable to pramipexol in MPTP‐treated animal model of Parkinson's disease: a direct comparison study. Journal of Neurochemistry 2009;111(4):1042-1050; https://doi.org/10.1111/j.1471-4159.2009.06381.x PMid:19765187
7. Reich SG, Savitt JM. Parkinson's Disease. Medical Clinics of North America 2019;103(2):337-350; https://doi.org/10.1016/j.mcna.2018.10.014 PMid:30704685
8. Ogungbenro K, Pertinez H, Aarons L. Empirical and Semi-Mechanistic Modelling of Double-Peaked Pharmacokinetic Profile Phenomenon Due to Gastric Emptying. AAPS J 2015;17(1):227-236; https://doi.org/10.1208/s12248-014-9693-5 PMid:25413723 PMCid:PMC4287295
9. Khan S, Shaikh MA, Shaikh N, et al. Analytical method development and validation of UV-visible spectrophotometric method for the estimation of CNS stimulant drug in bulk. IJPCA 2023;10(2):133-136; https://doi.org/10.18231/j.ijpca.2023.023
10. Anonymous. Skoog, Holler, Nieman. Principles of Instrumental Analysis, Fifth Edition, Thomson Asia Pvt. Ltd., Singapore, 2004, 300-325. n.d.
11. Joshi D. Analytical Method Development and Validation of UV-Visible Spectrophotometric Method for the Estimation of Saxagliptin in Gastric Medium. GJPPS 2021;8(2); https://doi.org/10.19080/GJPPS.2021.08.555735
12. Kumari B, Khansili A. Analytical Method Development and Validation of UV-visible Spectrophotometric Method for the Estimation of Vildagliptin in Gastric Medium. Drug Res (Stuttg) 2020;70(09):417-423; https://doi.org/10.1055/a-1217-0296 PMid:32746479
13. Sharma S, Lohan S, Murthy RSR. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Drug Development and Industrial Pharmacy 2014;40(7):869-878; https://doi.org/10.3109/03639045.2013.789051 PMid:23600649
14. Mali A, Bhilare S, Chaudhari B, et al. Development and Validation of UV Spectrophotometric Method for the Determination of Ibuprofen by Using Quality by Design (QbD) Approach. Int J Pharm Sci Rev Res 2024;84(6); https://doi.org/10.47583/ijpsrr.2024.v84i06.014
15. Sharma D, Kaur P, Singh G, et al. Development and Validation of Stability Indicating UV-Visible Spectrophotometric Method for Simultaneous Estimation of Neem (Azadirachtin) and Curcumin in Pharmaceutical Tablet Dosage Form. Analytical Chemistry Letters 2019;9(4):564-581; https://doi.org/10.1080/22297928.2019.1652113
16. Anonymous. Validation of Analytical Procedures: Text and Methodology Q2 (R1). ICH Harmonized Tripartite Guideline, 1994. n.d.
17. Patil SD, Chaure SK, Rahman MAH, et al. Development and Validation of Simple UV-Spectrophotometric Method for the Determination of Empagliflozin. Asian Jour Pharmac Anal 2017;7(1):18; https://doi.org/10.5958/2231-5675.2017.00004.7
18. Trivedi S, Belgamwar V, Wadher K, et al. Development and Validation of a UV Spectrophotometric Method for the Estimation of the Synthesized Lentinan-Congo Red Complex. J Appl Spectrosc 2022;89(2):344-349; https://doi.org/10.1007/s10812-022-01364-y
19. Rapalli VK, Kaul V, Gorantla S, et al. UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2020;224:117392; https://doi.org/10.1016/j.saa.2019.117392 PMid:31330421
20. R. Wani P, Jadhav V, Jain A, et al. UV Spectrophotometric Method Development and Validation for the Determination of Nirmatrelvir Antiviral Drug in Bulk and its In-house Formulation. AJPA 2024;127-130; https://doi.org/10.52711/2231-5675.2024.00022
21. R S, Karwa P, Kusum Devi V. Development and Validation of UV Spectrophotometric Method for Determination of Tacrolimus in Bulk and Capsule Dosage Form. RGUHS JPharm Sci 2022;12(3):12433429; https://doi.org/10.26463/rjps.12_3_4
22. Pande S, Parikh JR. Development and Validation of UV- Spectrophotometric Method for estimation of Vancomycin Hydrochloride. J Drug Delivery Ther 2019;9(3-s):116-118; https://doi.org/10.22270/jddt.v9i3-s.2959
23. Ayalasomayajula SP, Dole K, He Y-L, et al. Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects. Current Medical Research and Opinion 2007;23(12):2913-2920; https://doi.org/10.1185/030079907X233296 PMid:17931461
24. Sharma S, Sharma JB, Bhatt S, et al. Method Development and Validation of UV Spectrophotometric Method for the Quantitative Estimation of Curcumin in Simulated Nasal Fluid. Drug Res (Stuttg) 2020;70(08):356-359; https://doi.org/10.1055/a-1193-4655 PMid:32575135
25. Srivastava N, Bansal A, Aggarwal K, et al. Development and Validation of UV Spectrophotometric Method for the Quantitative Estimation of Quercetin in Bulk Followed by Its Solubility Studies. J Appl Spectrosc 2024;91(3):700-708; https://doi.org/10.1007/s10812-024-01773-1
26. Kumar M, Shukla AK, Bishnoi RS, et al. Development of UV Spectrophotometric Method for The Determination of Benidipine Hydrochloride by Using Quality by Design (Qbd) Approach. Int J App Pharm 2018;10(4):92; https://doi.org/10.22159/ijap.2018v10i4.26623
27. Anonymous. Note for Guidance on Validation of Analytical Procedures: Text and Methodology. European Medicines Agency, 1995, 1-15. n.d.
Published
Abstract Display: 144 
PDF Downloads: 122 PDF Downloads: 55 How to Cite
Issue
Section
Copyright (c) 2025 Oyitabu Ifunanya Mercy, DN Nayana , K Shreya , J Baseer UL Sumeer , MS Lingesh Kumar , Gagana D. Nayak, Rama Bukka, Rama Nargund, Vijaya S Bhaskar, Shravan L. Nargund, Shachindra L. Nargund, Vemula Kusum Devi, Vijaya G Joshi, Nidhi Malviya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.